DK1553832T3 - Præparater og fremgangsmåder til celleseparering - Google Patents

Præparater og fremgangsmåder til celleseparering

Info

Publication number
DK1553832T3
DK1553832T3 DK03759533T DK03759533T DK1553832T3 DK 1553832 T3 DK1553832 T3 DK 1553832T3 DK 03759533 T DK03759533 T DK 03759533T DK 03759533 T DK03759533 T DK 03759533T DK 1553832 T3 DK1553832 T3 DK 1553832T3
Authority
DK
Denmark
Prior art keywords
methods
cell separation
preparations
separation preparations
reagents
Prior art date
Application number
DK03759533T
Other languages
Danish (da)
English (en)
Inventor
Daniel P Collins
Joel H Hapke
Carol A Buchert
Original Assignee
Bioe Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bioe Inc filed Critical Bioe Inc
Application granted granted Critical
Publication of DK1553832T3 publication Critical patent/DK1553832T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0081—Purging biological preparations of unwanted cells
    • C12N5/0087—Purging against subsets of blood cells, e.g. purging alloreactive T cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/721—Dextrans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/727—Heparin; Heparan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0081—Purging biological preparations of unwanted cells
    • C12N5/0093—Purging against cancer cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Microbiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cell Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Oncology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Mycology (AREA)
  • Hematology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Manufacture And Refinement Of Metals (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DK03759533T 2002-09-27 2003-09-26 Præparater og fremgangsmåder til celleseparering DK1553832T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US41469202P 2002-09-27 2002-09-27
PCT/US2003/030265 WO2004029208A2 (en) 2002-09-27 2003-09-26 Cell separation compositions and methods

Publications (1)

Publication Number Publication Date
DK1553832T3 true DK1553832T3 (da) 2007-10-01

Family

ID=32043402

Family Applications (1)

Application Number Title Priority Date Filing Date
DK03759533T DK1553832T3 (da) 2002-09-27 2003-09-26 Præparater og fremgangsmåder til celleseparering

Country Status (13)

Country Link
US (1) US6933148B2 (de)
EP (1) EP1553832B1 (de)
JP (1) JP4344696B2 (de)
CN (1) CN100350040C (de)
AT (1) ATE366801T1 (de)
AU (1) AU2003275260B2 (de)
CA (1) CA2499826C (de)
DE (1) DE60314898T2 (de)
DK (1) DK1553832T3 (de)
IL (1) IL167624A (de)
MX (1) MXPA05003260A (de)
RU (1) RU2346039C2 (de)
WO (1) WO2004029208A2 (de)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE493186T1 (de) * 2001-04-10 2011-01-15 Bioe Llc Zelltrennungszusammensetzungen und -verfahren
US8603345B2 (en) * 2003-02-13 2013-12-10 Becton, Dickinson And Company Devices for component removal during blood collection, and uses thereof
US7622108B2 (en) 2004-04-23 2009-11-24 Bioe, Inc. Multi-lineage progenitor cells
WO2005108559A2 (en) 2004-04-23 2005-11-17 Bioe, Inc. Multi-lineage progenitor cells
US8263404B2 (en) * 2005-04-08 2012-09-11 Medical Discovery Partners Llc Method for enriching rare cell subpopulations from blood
US7875453B2 (en) * 2006-06-14 2011-01-25 Bioe Llc Differentiation of multi-lineage progenitor cells to hepatocytes
KR101456728B1 (ko) 2006-09-08 2014-10-31 메디뮨 엘엘씨 인간화 항-ｃｄ19 항체, 및 이것의 종양학, 이식 및 자가면역 질환의 치료에서의 용도
US7713688B2 (en) * 2007-01-26 2010-05-11 Bioe, Llc Methods and compositions for depleting specific cell populations from blood tissues
BRPI0915582A2 (pt) * 2008-06-06 2016-01-26 Baylor Res Inst anticorpos anto-cd8 que bloqueiam a sensibilização de efetores citotóxicos e levam à geração de células t cd8+ reguladoras
WO2010011672A2 (en) 2008-07-21 2010-01-28 Becton, Dickinson And Company Density phase separation device
CA2731155C (en) 2008-07-21 2013-09-24 Becton, Dickinson And Company Density phase separation device
CA2731076C (en) 2008-07-21 2013-06-11 Becton, Dickinson And Company Density phase separation device
CN101403749B (zh) * 2008-11-17 2012-11-07 北京大学 通过葡聚糖特异性抗体辅助诊断自身免疫性疾病的试剂盒
ES2763364T3 (es) 2009-05-15 2020-05-28 Becton Dickinson Co Dispositivo de separación de fase de densidad
CA2774193C (en) * 2009-09-15 2020-08-25 The University Of Tokyo Novel method for producing differentiated cells
US20130288227A1 (en) * 2010-11-01 2013-10-31 Daniel P. Collins Methods and compositions for cell separation of blood tissues
EP2643694B1 (de) * 2010-11-24 2018-01-03 Litron Laboratories Ltd. Schneller in-vivo-genmutations-assay auf basis des pig-a-gens
WO2012148549A1 (en) 2011-02-25 2012-11-01 Benaroya Research Institute Detection of an immune response
CN102839152A (zh) * 2011-06-20 2012-12-26 中国科学院上海生命科学研究院 一种快速高效获得抗原特异性b细胞的方法
ES2602500T3 (es) * 2011-11-25 2017-02-21 Miltenyi Biotec Gmbh Método de separación celular
US20140295542A1 (en) * 2013-04-01 2014-10-02 Bhc Technology Holdings Llc Cell separation compositions and methods for separating and recovering therapeutic cells in blood tissue
US9694359B2 (en) 2014-11-13 2017-07-04 Becton, Dickinson And Company Mechanical separator for a biological fluid
CN108586612A (zh) * 2018-03-27 2018-09-28 深圳联合医学科技有限公司 一种适用于检测人外周血表达cd161分子亚群淋巴细胞的单克隆抗体的制备方法
RU2020122145A (ru) * 2020-07-03 2022-01-04 Петр Иванович Никитин Композиция и способ для улучшения эффективности или снижения побочных эффектов терапевтического агента, используемого для доставки нуклеиновых кислот
CN118388650B (zh) * 2024-06-28 2024-08-27 杭州赛基生物科技有限公司 一种抗CD235a单克隆抗体及其制备方法和应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4946778A (en) 1987-09-21 1990-08-07 Genex Corporation Single polypeptide chain binding molecules
US5840502A (en) 1994-08-31 1998-11-24 Activated Cell Therapy, Inc. Methods for enriching specific cell-types by density gradient centrifugation
US6117985A (en) * 1995-06-16 2000-09-12 Stemcell Technologies Inc. Antibody compositions for preparing enriched cell preparations
US5877299A (en) 1995-06-16 1999-03-02 Stemcell Technologies Inc. Methods for preparing enriched human hematopoietic cell preparations
US6146628A (en) 1995-07-11 2000-11-14 Regents Of The University Of Minnesota And Rutgers Biotherapeutic agents comprising recombinant PAP and PAP mutants
US6491917B1 (en) 1998-07-31 2002-12-10 Stemcell Technologies Inc. Antibody composition for debulking blood and bone marrow samples from CML patients
US6153113A (en) 1999-02-22 2000-11-28 Cobe Laboratories, Inc. Method for using ligands in particle separation
ATE292282T1 (de) * 1999-05-28 2005-04-15 Stemcell Technologies Inc Verfahren zur zellseparation unter verwendung von immunorosetten
ATE493186T1 (de) * 2001-04-10 2011-01-15 Bioe Llc Zelltrennungszusammensetzungen und -verfahren

Also Published As

Publication number Publication date
WO2004029208A3 (en) 2005-04-14
CN1735346A (zh) 2006-02-15
EP1553832A2 (de) 2005-07-20
RU2346039C2 (ru) 2009-02-10
DE60314898D1 (de) 2007-08-23
DE60314898T2 (de) 2008-03-13
MXPA05003260A (es) 2005-09-12
WO2004029208A2 (en) 2004-04-08
EP1553832B1 (de) 2007-07-11
AU2003275260A1 (en) 2004-04-19
CA2499826C (en) 2015-03-24
RU2005112731A (ru) 2006-01-20
US20040062766A1 (en) 2004-04-01
IL167624A (en) 2009-12-24
US6933148B2 (en) 2005-08-23
CA2499826A1 (en) 2004-04-08
JP2006500932A (ja) 2006-01-12
ATE366801T1 (de) 2007-08-15
AU2003275260B2 (en) 2008-01-24
EP1553832A4 (de) 2006-02-01
JP4344696B2 (ja) 2009-10-14
CN100350040C (zh) 2007-11-21

Similar Documents

Publication Publication Date Title
DK1553832T3 (da) Præparater og fremgangsmåder til celleseparering
DE60238801D1 (de) Zelltrennungszusammensetzungen und -verfahren
WO2007067782A3 (en) Compositions and methods for inducing the activation of immature monocytic dendritic cells
ATE536187T1 (de) Hla-klasse-i- und -klasse-ii-bindende peptide und ihre verwendungen
DE69802191D1 (de) Festphase nukleinsäure-isolierung
CY1111098T1 (el) Bodipy διαιθυλοακεταλη αμινοακεταλδεϋδης
NO20065084L (no) Interferon-alfa polypeptider og konjugater
DK1532261T3 (da) Fremgangsmåder og DNA-konstrukter til produktion af polypeptider med højt udbytte
ATE519536T1 (de) Methode zum trennen von zellen
WO2004111075A3 (en) Alternative reading frame polypeptides for treatment
NO20052363L (no) Interferon-alfa polypeptider og konjugater
WO2004055491A3 (en) Novel method for sequence determination using nmr
EP2117592A4 (de) Verfahren und zusammensetzung zur entfernung spezifischer zellpopulationen aus blutgeweben
DK1530637T3 (da) Carlsberg-subtilisin-proteiner med nedsat immunogenitet
TW200801039A (en) Separation methods
WO2007127659A3 (en) Methods and compositions for separating cells
AU7963901A (en) Method for electrophoretically separating membrane proteins
EP1730276B8 (de) Verfahren, chip, vorrichtung und system zur extraktion biologischer materialien
ZA200610470B (en) Novel sequence for improving expression of nucleic acid
DK1723233T3 (da) Fremgangsmåde til berigelse og/eller adskillelse prokaryotisk DNA ved hjælp af et protein, som specifikt binder DNA indeholdende ikke-methylerede CPG-motiver
ES2421558T3 (es) Anticuerpos específicos de cáncer y proteínas de superficie celular
WO2004072262A3 (en) Cultured cd14+ antigen presenting cells
WO2004067750A3 (en) Xenorhabdus tc proteins and genes for pest control
WO2004016803A3 (en) Method of enhancing cd4+ t cell responses
WO2012061291A3 (en) Methods and compositions for cell separation of blood tissues